Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Toronto
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Intellipharmaceutics International Inc/CA

+ Add to Watchlist

I:CN

3.1800 CAD 0.1200 3.64%

As of 15:59:59 ET on 04/17/2015.

Snapshot for Intellipharmaceutics International Inc/CA (I)

Open: 3.3300 Day's Range: 3.0100 - 3.3300 Volume: 33,850
Previous Close: 3.3000 52wk Range: 2.1400 - 5.1500 1-Yr Rtn: -18.04%

Stock Chart for I

No chart data available.
  • I:CN 3.1800
  • 1D
  • 1M
  • 1Y
3.3000
Interactive I Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for I

Current P/E Ratio (ttm) -
Estimated P/E(11/2015) -
Relative P/E vs. SPTSX -
Earnings Per Share (USD) (ttm) -0.3000
Est. EPS (USD) (11/2015) -0.1330
Est. PEG Ratio -
Market Cap (M CAD) 74.86
Shares Outstanding (M) 23.54
30 Day Average Volume 12,940
Price/Book (mrq) 14.6136
Price/Sale (ttm) 11.5980
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/07/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for I

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for I

IntelliPharmaCeutics International Inc. develops drug delivery technologies. The Company has developed a controlled release drug delivery platform to provide life cycle management or new chemical entity delivery system solutions for virtually any small molecule.

Isa OdidiChairman/CEOAmina OdidiPresident/COO
Domenic Della PennaChief Financial OfficerJohn Newell AllportVP:Legal Affairs & Licensing
More Company Profile & Key Executives for I

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil